Skip to content
Thomas-Storme_large

Affiliation

CHU Robert Debre / Assistance Publique - Hopitaux de Paris

Country

France

1. Current Status, Position

Dr Thomas Storme is currently a Hospital Pharmacist at Robert Debré Hospital, the largest French paediatric hospital. He is in charge of compounding (CIVAS, including chemotherapies, TPN admixtures, oral drugs) and pharmaceutical quality control. Dr Storme is also Pharmacologist and involved in therapeutic drug monitoring, in paediatric patients.

2. Education

Dr Thomas Storme studied pharmacy at Paris Descartes University and became a licensed pharmacist in 2006. Thomas Storme made his residency at Paris area hospitals. In 2007 he obtained a PhD in medicinal chemistry and experimental pharmacology at Paris Descartes University for his work on the conception, synthesis and evaluation of new ifosfamide analogues designed to lower neurotoxic and nephrotoxic side-effects.

3. Research Area

Dr Thomas Storme’s research focuses on parenteral nutrition, improving paediatric drug compounding and paediatric pharmacology.

4. Conflict of interest:  Dr Thomas Storme was on the Advisory Board of Baxter’s Parenteral Nutrition Compounders held in Chicago in March 2018. He also gave a lesson on paed parenteral nutrition for Fresenius Kabi’s business team.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.